Successful recovery from critical COVID-19 pneumonia with extracorporeal membrane oxygenation: A case report.
ARDS, acute respiratory distress syndrome
Acute respiratory distress syndrome
COVID-19, coronavirus disease
Coronavirus
ECMO, extracorporeal membrane oxygenation
Gamma-globulin
IVIG, intravenous immune globulin
Organizing pneumonia
RT-PCR, reverse transcription polymerase chain reaction
SARS-CoV-2, severe acute respiratory syndrome coronavirus 2
Journal
Respiratory medicine case reports
ISSN: 2213-0071
Titre abrégé: Respir Med Case Rep
Pays: England
ID NLM: 101604463
Informations de publication
Date de publication:
2020
2020
Historique:
received:
20
04
2020
revised:
27
05
2020
accepted:
28
05
2020
entrez:
12
6
2020
pubmed:
12
6
2020
medline:
12
6
2020
Statut:
epublish
Résumé
A public health emergency of current international concern is the outbreak of a severe respiratory illness, that is, coronavirus disease (COVID-19). The disease initially started in Wuhan, China, and it rapidly spread to most regions of the world. Herein, we report a case of critical COVID-19 pneumonia treated with extracorporeal membrane oxygenation from symptom onset day 19 (SOD#19) to SOD#30. We describe the patient's clinical course, from mild symptoms at the time of illness onset to symptoms of severe pneumonia as the illness progressed. We provide important information regarding our clinical experience for further understanding of management discrepancies, as treatment with extracorporeal membrane oxygenation or pharmacotherapy (e.g., antivirals, immunomodulators, and glucocorticoids) is often dependent on the severity of symptoms.
Identifiants
pubmed: 32523870
doi: 10.1016/j.rmcr.2020.101113
pii: S2213-0071(20)30171-4
pii: 101113
pmc: PMC7261438
doi:
Types de publication
Case Reports
Langues
eng
Pagination
101113Informations de copyright
© 2020 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Hong Kong Med J. 2003 Dec;9(6):399-406
pubmed: 14660806
JAMA. 2020 Mar 13;:
pubmed: 32167538
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
JAMA. 2020 Mar 3;:
pubmed: 32125362
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
JAMA. 2020 Feb 19;:
pubmed: 32074258
N Engl J Med. 2020 Mar 5;382(10):929-936
pubmed: 32004427
JAMA. 2020 Feb 24;:
pubmed: 32091533
JAMA. 2020 Feb 7;:
pubmed: 32031570
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
JAMA Intern Med. 2020 Mar 13;:
pubmed: 32167524
Thorax. 2004 Mar;59(3):252-6
pubmed: 14985565
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
JAMA. 2018 Dec 4;320(21):2251-2259
pubmed: 30347031
Lancet. 2020 Feb 15;395(10223):473-475
pubmed: 32043983
Antimicrob Agents Chemother. 2014 Aug;58(8):4875-84
pubmed: 24841269
Crit Care Med. 2020 Feb;48(2):e98-e106
pubmed: 31939808
J Med Virol. 2020 May;92(5):479-490
pubmed: 32052466
J Formos Med Assoc. 2020 Mar;119(3):747-751
pubmed: 32113824